awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39353122-63AC1676-84C1-4E05-81DB-057D52BD3222
Q39353122-63AC1676-84C1-4E05-81DB-057D52BD3222
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39353122-63AC1676-84C1-4E05-81DB-057D52BD3222
Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease.
P2860
Q39353122-63AC1676-84C1-4E05-81DB-057D52BD3222
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39353122-63AC1676-84C1-4E05-81DB-057D52BD3222
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bc97da9b47b26cf75b038604bba785d76e5f153f
P2860
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial.